Opportunities and challenges for human papillomavirus vaccination in China
Current estimates of the HPV infection rate in China vary by geographic region (9.6–23.6%), with two age peaks in prevalence in women ≤20–25 years of age and 50–60 years of age. HPV-16, 52 and 58 are the most commonly-detected HPV genotypes in the Chinese population. In China, five HPV vaccines are...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis Group
2024-12-01
|
| シリーズ: | Human Vaccines & Immunotherapeutics |
| 主題: | |
| オンライン･アクセス: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2329450 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|